Centene reaffirms FY2025 adjusted EPS guidance above $7.25 at Barclays conference

CENTENE CORP

Reaffirms 2025 adjusted diluted EPS guidance of greater than $7.25.
Presentation at Barclays 27th Annual Global Healthcare Conference on March 12, 2025 at 2:30 p.m. EDT.
Live audio webcast available; replay to be posted on Centene's investor relations website.

item 7.01

CENTENE CORP filing history →

Source: SEC EDGAR

accession 0001071739-25-000042

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.